Principal Investigator:
Noah Lechtzin, M.D., M.H.S.
Department:
Medicine
Research in the Noah Lechtzin Lab investigates several important aspects of cystic fibrosis (CF), including the impact of antibiotic-resistant bacterial infections in CF patients and new therapy options for individuals with CF. Our research into new CF therapies has included studies on home electronic symptom and lung function monitoring, transbronchial needle aspiration and bedside percutaneous endoscopic gastrostomy tube placement. We also explore the role of metabolic complications in CF patients by examining how the disease is impacted by factors such as vitamin D deficiency, osteoporosis and testosterone deficiency.
Research Areas: osteoporosis, cystic fibrosis, pulmonary medicine, metabolism, antibiotic-resistant bacterial infections, testosterone